Initiation of Global Phase 3 Trial of Alagille Syndrome Treatment
source: pixabay.com

Initiation of Global Phase 3 Trial of Alagille Syndrome Treatment

Albireo has recently initiated their Phase 3 ASSERT trial, according to GlobeNewswire. This study will evaluate odevixibat as a treatment for Alagille syndrome. This therapy fits well with Albireo's mission,…

Continue Reading Initiation of Global Phase 3 Trial of Alagille Syndrome Treatment
Odevixibat Shows Promise in Progressive Familial Intrahepatic Cholestasis
source: pixabay.com

Odevixibat Shows Promise in Progressive Familial Intrahepatic Cholestasis

According to a story from GlobeNewswire, the rare disease liver company Albireo Pharma, Inc., recently announced positive results from a phase 3 study testing the company's experimental drug odevixibat as…

Continue Reading Odevixibat Shows Promise in Progressive Familial Intrahepatic Cholestasis
TLMdX Accepts Late-Breaking Results on Odevixibat for PFIC
Arcaion / Pixabay

TLMdX Accepts Late-Breaking Results on Odevixibat for PFIC

Later this week, the American Association for the Study of Liver Diseases (AASLD) will hold its virtual The Liver Meeting Digital Experience (TLMdX). Altogether, TLMdX will last from November 13-16.…

Continue Reading TLMdX Accepts Late-Breaking Results on Odevixibat for PFIC

New 5-Year Survival Data Available on Maralixibat for PFIC2

This year, the Digital International Liver Congress took place online from August 27-29, thanks to COVID-19. During the conference, biopharmaceutical company Mirum Pharmaceuticals announced data from its Phase 2 INDIGO…

Continue Reading New 5-Year Survival Data Available on Maralixibat for PFIC2
First International Awareness Day for Alagille Syndrome was Held January 24th
source: pixabay.com

First International Awareness Day for Alagille Syndrome was Held January 24th

International Alagille Awareness Day The very first International Alagille Awareness day was held on January 24th, 2020. What is Alagille syndrome? It is a rare disease which effects the heart,…

Continue Reading First International Awareness Day for Alagille Syndrome was Held January 24th
Phase 3 Trial of Experimental Progressive Familial Intrahepatic Cholestasis Drug for Pediatric Patients Begins
DarkoStojanovic / Pixabay

Phase 3 Trial of Experimental Progressive Familial Intrahepatic Cholestasis Drug for Pediatric Patients Begins

According to a story from drugs.com, the biopharmaceutical company Mirum Pharmaceuticals recently announced that they have begun dosing the first patient in a phase 3 clinical trial. This clinical trial…

Continue Reading Phase 3 Trial of Experimental Progressive Familial Intrahepatic Cholestasis Drug for Pediatric Patients Begins
4-Year-Old Girl Joins Clinical Trial to Relieve Itching Associated With Alagille Syndrome
birgl / Pixabay

4-Year-Old Girl Joins Clinical Trial to Relieve Itching Associated With Alagille Syndrome

According to a story from abc13.com, Makenna Brown, a four-year-old girl from Texas, has been plagued by relentless itching thanks to her Alagille syndrome, a rare genetic disorder. Her distressed…

Continue Reading 4-Year-Old Girl Joins Clinical Trial to Relieve Itching Associated With Alagille Syndrome
Experimental Treatment for Biliary Atresia Gets Orphan Drug Designation in the EU
Capri23auto / Pixabay

Experimental Treatment for Biliary Atresia Gets Orphan Drug Designation in the EU

According to a story from Market Screener, the drug developer Albireo Pharma, Inc., recently announced that its investigational product candidate A4250 has earned Orphan Drug designation from the European Commission.…

Continue Reading Experimental Treatment for Biliary Atresia Gets Orphan Drug Designation in the EU
New Development Deal Struck for Experimental Alagille Syndrome Treatment
rawpixel / Pixabay

New Development Deal Struck for Experimental Alagille Syndrome Treatment

According to a story from prnewswire.com, the drug developer Mirum Pharmaceuticals recently announced that is has entered an agreement with Shire which grants exclusive rights for marketing and development of…

Continue Reading New Development Deal Struck for Experimental Alagille Syndrome Treatment
PatientWorthy is Offering Two Tickets to the First Annual Alagille Syndrome Alliance Gala
Source: Pixabay

PatientWorthy is Offering Two Tickets to the First Annual Alagille Syndrome Alliance Gala

PatientWorthy will be offering a pair of tickets to the Alagille Syndrome Alliance's (ALGSA) First Annual Gala. The tickets will be available for patients or caregivers in the San Diego…

Continue Reading PatientWorthy is Offering Two Tickets to the First Annual Alagille Syndrome Alliance Gala
By Observing the Effects of Alagille Syndrome, Researchers Discover How Liver Tissue Can Transform and Heal
[Source: pixabay.com]

By Observing the Effects of Alagille Syndrome, Researchers Discover How Liver Tissue Can Transform and Heal

According to a story from PR Newswire, a group of scientists have managed to discover a mechanism that allows the liver to repair damage it has sustained. This discovery may…

Continue Reading By Observing the Effects of Alagille Syndrome, Researchers Discover How Liver Tissue Can Transform and Heal